Skip to main content

Market Overview

Mid-Afternoon Market Update: Cubic Tumbles Following Q4 Results; Hepion Pharmaceuticals Shares Climb


Toward the end of trading Thursday, the Dow traded down 0.01% to 27,818.51 while the NASDAQ fell 0.07% to 8,520.75. However, the S&P rose 0.01% to 3,108.51.

Leading and Lagging Sectors

Energy shares climbed 1.4% on Thursday. Meanwhile, top gainers in the sector included McDermott International, Inc. (NYSE: MDR), up 29%, and Pacific Drilling S.A. (NYSE: PACD), up 10%.

In trading on Thursday, real estate shares fell 1.1%.

Top Headline

Macy's Inc (NYSE: M) reported downbeat sales for its third quarter and lowered FY19 guidance.

Macy's reported third-quarter earnings of 7 cents per share on Thursday. This is a 74.07% decrease over earnings of 27 cents per share from the same period last year. The company reported quarterly sales of $5.173 billion, which missed the analyst consensus estimate of $5.32 billion.

Macy's cut fiscal year 2019 EPS guidance from $2.85-$3.05 to $2.57-$2.77 versus the $2.79 estimate. The company lowered FY19 same-store sales guidance from flat to up 1% to down 1-1.5%

Equities Trading UP

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares shot up 43% to $3.45 after the thinly-traded, nano-cap biotech announced results from an animal study of its lead product candidate CRV431. New Jersey-based Hepion said CRV431 prevented the development of liver cirrhosis in a highly aggressive, preclinical model of liver disease.

Shares of Stage Stores, Inc. (NYSE: SSI) got a boost, shooting up 43% to $3.1784 after the company reported Q3 results.

TD Ameritrade Holding Corporation (NASDAQ: AMTD) shares were also up, gaining 18% to $49.01. Charles Schwab (NYSE: SCHW) is looking to acquire TD Ameritrade for $26 billion, Fox Business first reported. The deal could be announced as soon as today.

Equities Trading DOWN

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares tumbled 31% to $0.16. InVivo Therapeutics priced its 7 million share offering at $0.12 per share for gross proceeds $840,000.

Shares of Cubic Corporation (NYSE: CUB) were down 19% to $59.59 after the company reported worse-than-expected Q4 EPS results. The company also issued FY20 EPS guidance below analyst estimates.

Karuna Therapeutics, Inc. (NASDAQ: KRTX) was down, falling 25% to $81.79 after the company reported an offering of 2.6 million shares of its common stock at $96 per share.


In commodity news, oil traded up 2.7% to $58.52, while gold traded down 0.7% to $1,463.90.

Silver traded down 0.4% Thursday to $17.045, while copper fell 0.9% to $2.6245.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.4%, the Spanish Ibex Index fell 0.12%, while Italy’s FTSE MIB Index fell 0.31%. Meanwhile, the German DAX fell 0.16%, and the French CAC 40 fell 0.22% while UK shares fell 0.33%.


U.S. initial jobless claims were unchanged at 227,000 for the latest week. However, analysts were expecting a reading of 220,000.

The Philadelphia Fed manufacturing index increased to 10.4 for November, versus a reading of 5.6 in October.

U.S. existing home sales increased 1.9% to an annual rate of 5.46 million units in October, versus analysts’ expectations of 1.4% rise.

U.S. leading economic indicators declined 0.1% for October.

Domestic supplies of natural gas dropped 94 billion cubic feet for the week ended November 8, the U.S. Energy Information Administration reported. However, analysts projected a decline of 91 billion cubic feet.

Data on money supply for the recent week will be released at 4:30 p.m. ET.


Related Articles (AMTD + CUB)

View Comments and Join the Discussion!

Posted-In: Mid-Afternoon Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at